Bristol Myers Squibb Plans $2.3B Manufacturing Campus in Houston

• Bristol Myers Squibb selected Generation Park in Houston for a roughly 600,000-square-foot manufacturing campus representing an approximately $2.3 billion investment.
• The project is expected to create nearly 500 skilled jobs and about 2,000 construction and related jobs between 2027 and 2030.
• The flexible campus will manufacture small-molecule medicines, biologics and antibody-drug conjugates, with plans allowing the facility to expand and adapt over time.

What Bristol Myers Squibb Is Building in Houston

Bristol Myers Squibb has selected Generation Park in northeast Houston for a new advanced pharmaceutical manufacturing campus, bringing a major life sciences investment to one of the region's largest master-planned developments. The approximately 600,000-square-foot facility represents an estimated $2.3 billion investment and is expected to create nearly 500 skilled jobs once operational. The construction phase is also expected to generate about 2,000 construction and related jobs between 2027 and 2030. The Houston project is part of BMS' broader $40 billion, five-year commitment to U.S. research, technology and domestic manufacturing.

What The Campus Will Manufacture

The facility is being designed as a multi-modal manufacturing campus, giving BMS the ability to produce several categories of medicines at the same location. Planned capabilities include manufacturing small-molecule medicines, biologics and antibody-drug conjugates. The site will support drug-product and finished-goods manufacturing from late-stage development through commercial launch. Rather than locking the facility into one production configuration, BMS is planning the campus around modularity. Manufacturing capacity can be added or reconfigured as the company's pipeline and commercial needs change.

What Makes The Campus Flexible

The initial 600,000-square-foot facility is designed to grow beyond its opening configuration. BMS says the campus will incorporate advanced digital integration and automation, allowing manufacturing capabilities to be brought online as demand evolves. That flexibility is particularly important for a pharmaceutical manufacturer, where production requirements can change as medicines move from development into commercialization. The company expects the Houston campus to expand in both scale and capability over the long term.

What Generation Park Brings to The Project

Generation Park provides BMS with a large-scale development environment in northeast Houston. The master-planned development spans approximately 4,200 to 4,300 acres and is being developed by McCord Development. The project has increasingly become a destination for life sciences and advanced manufacturing users. More than $1 billion in office, multifamily, retail, civic, hospitality and industrial projects had already been constructed in Generation Park, according to McCord. The BMS investment follows another major pharmaceutical commitment in Generation Park. Eli Lilly purchased 236 acres for a planned $6.5 billion active pharmaceutical ingredient manufacturing campus, further strengthening the development's position within Houston's growing life sciences sector.

What The Investment Means for Houston

The BMS announcement adds another major pharmaceutical manufacturing project to Houston's expanding life sciences pipeline. For the commercial real estate market, the investment could have an impact beyond the manufacturing campus itself. Large pharmaceutical facilities typically create demand for specialized infrastructure, engineering and construction services, technical workers and supporting businesses. The project also reinforces northeast Houston's emergence as a major employment and investment center. Generation Park's combination of available land, infrastructure and access to the broader Houston region has helped it attract large institutional and corporate users.

What Comes Next for The Campus

Construction and related work are expected to take place between 2027 and 2030, with the facility designed to come online as BMS builds out its manufacturing capabilities. The company expects the campus to continue expanding beyond its initial footprint as its needs change. Texas is also supporting the project. Gov. Greg Abbott said BMS will receive a $4.89 million Texas Enterprise Fund grant, while the project also qualifies for additional benefits under the state's Jobs, Energy, Technology and Innovation program. For Generation Park, the project adds another major corporate anchor. For Houston, it strengthens the city's position as a destination for large-scale pharmaceutical manufacturing and life sciences investment.